Among the prominent genes in the ERAD pathway, Ufd1 and Cav1 genes were found to be highly expressed in the cancer group (G2) compared to the (G1) healthy control group (G2 vs. G1), while they were low expressed in all treatment groups (G3, 4 and 5). Here, UFD1 is linked to cancer.